Skip to Main Content

Paper Details

Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumors.
Oncotarget
33
2018
Author NameAffiliation
Philip J EbertLilly Research Laboratories
David E TimmLilly Research Laboratories
  • 1 - 2

Datasets

Release 1.2